XML 33 R19.htm IDEA: XBRL DOCUMENT v3.20.4
Supplemental Balance Sheet Information
 12 Months Ended
Dec. 31, 2020
Accounts Payable and Accrued Liabilities, Current [Abstract]  
Supplemental Balance Sheet Information Supplemental Balance Sheet Information
Accrued expenses reflected within current liabilities on the Company’s consolidated balance sheets consist of the following:
As of December 31,
(in thousands)20202019
Salaries and wages$65,310 $86,476 
Insurance reserves64,633 63,230 
Paid time off37,848 37,415 
Deferred payroll taxes (Note 3)
36,336 — 
Real estate taxes25,495 25,979 
Interest11,453 16,196 
Accrued utilities7,507 7,601 
Taxes payable3,806 1,360 
Other35,463 28,446 
Total$287,851 $266,703 

Other assets, net reflected on the Company's consolidated balance sheets consist of the following:

As of December 31,
(in thousands)20202019
Health care licenses(1)
$34,060 $35,198 
Lease security deposit3,180 49,102 
Other19,019 34,431 
Total$56,259 $118,731 

(1) Health care licenses are indefinite-lived intangible assets and are not subject to amortization.
Investment in Unconsolidated VenturesAs of December 31, 2019, the Company held a 51% equity interest, and Healthpeak owned a 49% interest, in the CCRC Venture, which owned and operated 16 entry fee CCRCs. The Company's ownership interests in the CCRC Venture were accounted for under the equity method of accounting. Refer to Note 4 for information on the Company's sale of the equity interest in the CCRC Venture on January 31, 2020 and movement of the remaining two entry fee CCRCs into a new unconsolidated venture. As a result of the recognition of the Company’s investment basis at the carrying amounts of the net assets contributed upon formation of the CCRC Venture and subsequent cash distributions, the Company's carrying amount of its equity method investment in the CCRC Venture property company was reduced below zero and the Company had recorded a $66.2 million equity method liability within other liabilities within the consolidated balance sheet as of December 31, 2019. As of December 31, 2020, other liabilities within the consolidated balance sheet included a $10.1 million equity method liability for the new unconsolidated venture which owns the remaining two entry fee CCRCs.